Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

9 May 2011 12:59

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing CHARLES TAYLOR shares to which voting rights are attached:ii

CONSULTING PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights RESTATEMENT OF UNDERLYING OWNERSHIP Other (please Following a reduction in stake of the ownership of Delta Lloyd NV by X specify): Aviva plc, Delta Lloyd NV and its Group of companies are no longer a controlled undertaking of Aviva plc. 3. Full name of person(s) subject to Aviva plc & its subsidiaries the notification obligation:iii 4. Full name of shareholder(s) (if Registered Holder: different from 3.):iv BNY Norwich Union Nominees Limited 39,825* Chase (GA Group) Nominees Limited 327,940* Chase Nominees Limited 19,179* Vidacos Nominees Limited 1,053* *denotes direct interest Chase Nominees Limited 10,805 Vidacos Nominees Limited 71,267 5. Date of the transaction and date on 06 May 2011 which the threshold is crossed or reached: v 6. Date on which issuer notified: 09 May 2011 7. Threshold(s) that is/are crossed or 13% to

GB0001883718 5,568,548 5,568,548 470,069 387,997 82,072 0.96% 0.20%

B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction

Type of financial Exercise Expiration Exercise/ Number of voting % of voting

instrument price date xvii Conversion rights instrument rights xix, xx period xviii refers to Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 470,069 1.16%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-

Aviva Investors Global Services Limited: Aviva plc (Parent Company) Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Proxy Voting: 10. Name of the proxy holder: See Section 4 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional Figures are based on a total number of voting rights of 40,344,664 as information: per the Company's Total Voting Rights Announcement of 27 September 2010 14. Contact Neil Whittaker, Aviva plc name: 15. Contact telephone 01603 684420 number:

vendor

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.